Seven studies [20, 23, 24, 26, 29, 30, 32] (8 trials) investigated the association between STAT3/p-STAT3 expression levels and ovarian carcinoma subtype (serous vs. nonserous) among a combined 1238 patients. Here, STAT3 is linked to ovarian carcinoma.